| 843 |
Centers for Disease Control and Prevention |
Html |
en |
Valley Fever: Working Toward a Solution | CDC Features |
Increasing public awareness about the fungal illness Coccidioidomycosis (Valley fever) brings key health leaders to Bakersfield, California. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5032 |
Centers for Disease Control and Prevention |
Html |
en |
Provider's Role in Importance of Vaccine Administration and Storage | CDC |
Provider's Role: Importance of Vaccine Admin. and Storage |
| Information Contact Center | 0.478211 |
| significant adverse event | 0.483417 |
| VAERS information | 0.494225 |
| influenza immunization recommendations | 0.517349 |
| public health authorities | 0.476902 |
| vaccine administration page | 0.639188 |
| vaccine administration | 0.657395 |
| Vaccine Information Statements | 0.615753 |
| Mild acute illness | 0.474063 |
| immunization provider | 0.497566 |
| vaccine side effects | 0.642069 |
| Immunization Action Coalitions | 0.508813 |
| mix vaccines | 0.556342 |
| Vaccine Adverse Event | 0.626162 |
| vaccine storage | 0.739425 |
| best possible results | 0.555212 |
| Immunization Action | 0.511056 |
| vaccine benefits | 0.628755 |
| package insert | 0.485213 |
| national vaccine safety | 0.615081 |
| immunization | 0.545754 |
| vaccines | 0.824564 |
| possible vaccine | 0.579268 |
| United States | 0.485458 |
| vaccine storage units | 0.64473 |
|
| Inspect vaccines | 0.561843 |
| equivalent component vaccines. | 0.474015 |
| properly calibrated thermometer | 0.478456 |
| effective vaccines | 0.57922 |
| vaccine doses | 0.654298 |
| careful patient histories | 0.480282 |
| Immunization Practices | 0.518607 |
| vaccine dose | 0.582795 |
| specific vaccines | 0.544057 |
| current Vaccine Information | 0.61838 |
| combination vaccine | 0.586194 |
| Immunization Action Coalition | 0.510382 |
| Rotate vaccine stock | 0.6327 |
| adverse events | 0.488727 |
| certain vaccines | 0.54229 |
| vaccine safety | 0.697223 |
| vaccine | 0.935593 |
| Record vaccine | 0.594738 |
| separate vaccines | 0.551334 |
| childhood immunization schedule | 0.516237 |
| Vaccine Injury Act | 0.609993 |
| currently recommended immunization | 0.521439 |
| cold chain procedures | 0.478796 |
| oldest vaccines | 0.561964 |
|
CLICK HERE |
| 8302 |
Centers for Disease Control and Prevention |
Html |
en |
CDC confirms rabies death in organ transplant recipient |
CDC confirms rabies death in organ transplant recipient |
| North Carolina | 0.572151 |
| immune globulin | 0.574228 |
| infectious diseases | 0.569035 |
| organ recipient | 0.664751 |
| incubation periods. CDC | 0.653003 |
| transplant-related transmission | 0.58528 |
| preliminary laboratory analysis | 0.637206 |
| infectious disease testing | 0.628906 |
| rabies post-exposure treatment | 0.84229 |
| Donor eligibility | 0.643753 |
| Disease Control | 0.585202 |
| donor’s organs | 0.669815 |
| rabid animal | 0.573159 |
| healthcare facility | 0.573942 |
| domestic animals | 0.574151 |
| rabies diagnosis | 0.80609 |
| prior case reports | 0.637333 |
| preventable viral disease | 0.623851 |
| animal exposures | 0.577523 |
| rabies transmission | 0.806222 |
| public health officials | 0.628625 |
| healthcare facilities | 0.57077 |
| virus—a raccoon type | 0.639264 |
| Maryland Department | 0.650665 |
| organ transplantation | 0.714064 |
|
| rabies incubation period | 0.865322 |
| potential organ donors | 0.678097 |
| usual source | 0.576285 |
| organ | 0.719333 |
| United States | 0.787215 |
| infectious risk | 0.570687 |
| human rabies | 0.768587 |
| anti-rabies vaccination | 0.570237 |
| donor | 0.797961 |
| organ recipients | 0.62073 |
| Organ procurement organizations | 0.674817 |
| current investigation | 0.573871 |
| raccoon-type rabies virus. | 0.856519 |
| organ donor | 0.695022 |
| rabies anti-rabies shots | 0.838483 |
| rabid animals | 0.574944 |
| CDC laboratories | 0.590955 |
| rabies | 0.98331 |
| healthcare teams | 0.571023 |
| tissue samples | 0.579854 |
| Organ screening | 0.61223 |
| previous resident | 0.569646 |
| initial donor | 0.646681 |
| recipient developed symptoms | 0.672859 |
|
CLICK HERE |
| 8796 |
Centers for Disease Control and Prevention |
Html |
null |
Extreme Heat and Your Health: Heat and People with Chronic Medical Conditions |
Extreme Heat Media Toolkit |
|
|
CLICK HERE |
| 8960 |
Centers for Disease Control and Prevention |
Html |
en |
Publications and Resources - Public Health Law |
null |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 9240 |
Centers for Disease Control and Prevention |
Html |
en |
U.S. Quarantine Stations - Health Communication |
Gateway to Health Communication and Social Marketing Practice - US Quarantine Stations |
| United States | 0.543228 |
| U.S. Quarantine Stations | 0.965633 |
| public health authorities | 0.278834 |
| single ill traveler | 0.294978 |
| Angeles Quarantine Station | 0.817098 |
| certain health conditions | 0.268316 |
| quarantinable diseases | 0.254367 |
| unvaccinated 15-year-old refugee | 0.235649 |
| Quarantine Stations work | 0.488228 |
| public health professionals | 0.2858 |
| U.S. federal agencies | 0.275162 |
| local health departments | 0.247098 |
| public health | 0.524245 |
| internal CDC partners | 0.257762 |
|
| California public health | 0.254162 |
| additional measles cases | 0.328318 |
| public health officers | 0.274006 |
| Acute Respiratory Syndrome | 0.2345 |
| communicable disease | 0.464971 |
| highly contagious disease | 0.296989 |
| ill travelers | 0.210273 |
| Executive Order | 0.22847 |
| measles outbreak | 0.226767 |
| Los Angeles Quarantine | 0.824227 |
| viral hemorrhagic fevers | 0.247692 |
| contagious diseases | 0.213878 |
| quarantine travelers | 0.39903 |
| CDC Los Angeles | 0.2583 |
|
CLICK HERE |
| 11872 |
Centers for Disease Control and Prevention |
Html |
en |
Conversations with the CDC Director: Pierre Rollin |
The CDC Director’s webpage offers information on Dr. Thomas Frieden, who became the agency’s 16th director in June 2009. The pages features information on Dr. Frieden’s Weekly Focus, the Latest from Dr. Frieden (his RSS feed), and links to his bio, statements, videos, press releases, media appearances, photos, presentations, and speeches. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 13081 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Nanotechnology Research Highlighted at the 2015Meeting of the Society of Toxicology | NIOSH Press Release |
The National Institute for Occupational Safety and Health (NIOSH) will participate in the 54th annual meeting of the Society of Toxicology (SOT) taking place March 22–16 in San Diego. More than 40 sessions will present NIOSH research at this gathering, which draws more than 6,500 toxicologists. |
| risk assessments | 0.260165 |
| NIOSH researchers | 0.919152 |
| respiratory/inhalation toxicology | 0.312728 |
| new findings | 0.262919 |
| effective recommendations | 0.263749 |
| U.S. Centers | 0.263485 |
| DNA damage | 0.26131 |
| internal dose studies | 0.409022 |
| inhalation exposure | 0.293419 |
| exposure measurements | 0.270346 |
| Nanotechnology Research Center | 0.431461 |
| download NIOSH | 0.680974 |
| specific class | 0.269975 |
| Occupational Safety | 0.458816 |
| responsible development | 0.26175 |
| potential occupational health | 0.427426 |
| San Diego | 0.295732 |
| SOT annual meeting | 0.531823 |
| journal Particle | 0.270711 |
| Disease Control | 0.263328 |
| national priority | 0.263533 |
| 54th annual meeting | 0.481356 |
| work-related injuries | 0.26152 |
|
| Press Contact | 0.299331 |
| Health Act | 0.272482 |
| Cancer’s decision | 0.264563 |
| multi-walled carbon nanotubes. | 0.481527 |
| engineered nanomaterials | 0.283608 |
| National Institute | 0.297149 |
| NIOSH research | 0.785065 |
| nanomaterial workforce | 0.279687 |
| latest science | 0.279773 |
| complete listing | 0.260142 |
| field studies | 0.26486 |
| lung adenocarcinoma | 0.290724 |
| virtual center | 0.265929 |
| key starting point | 0.393189 |
| Stephanie Stevens | 0.295018 |
| major focus | 0.282067 |
| NIOSH staff | 0.768109 |
| multi-walled carbon nanotubes | 0.500001 |
| vital technology | 0.257085 |
| Fibre Toxicology | 0.308188 |
| Federal agency | 0.257813 |
| International Agency | 0.270297 |
| potential hazards | 0.278737 |
|
CLICK HERE |
| 13280 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Responder: Selcen |
CDC works 24/7 saving lives, protecting people from health threats, and saving money to have a more secure nation. A US federal agency, CDC helps make the healthy choice the easy choice by putting science and prevention into action. CDC works to help people live longer, healthier and more productive lives. |
| U.S. Agency | 0.48132 |
| CDC’s National | 0.491876 |
| safety professionals | 0.47834 |
| head covers | 0.486129 |
| greatest possible protection | 0.572607 |
| unique opportunity | 0.484651 |
| fluid resistance | 0.474292 |
| improved PPE | 0.706125 |
| go-to experts | 0.504052 |
| real end-users | 0.484582 |
| workplace hazards | 0.49134 |
| government agencies | 0.481091 |
| emergency response | 0.47961 |
| sufficient protection | 0.478688 |
| personal protective equipment | 0.579485 |
| World Health Organization | 0.555198 |
| NIOSH | 0.442273 |
| infectious materials | 0.486038 |
| fluid-resistant garment | 0.482899 |
| common misunderstanding | 0.491798 |
| Selcen | 0.750684 |
| hot environments | 0.480651 |
| Ebola patients | 0.567537 |
| Ebola | 0.665703 |
| specific type | 0.476517 |
|
| Ebola epidemic | 0.560715 |
| footwear covers | 0.485913 |
| PPE | 0.970721 |
| United States | 0.496546 |
| critical component | 0.495402 |
| Ebola responders | 0.604015 |
| particular attention | 0.474297 |
| chemical agents | 0.48803 |
| International Development | 0.481267 |
| physical scientist | 0.487103 |
| viral penetration resistance | 0.541283 |
| proper selection | 0.483824 |
| n’t work | 0.481623 |
| occupational safety | 0.559752 |
| protective clothing | 0.57303 |
| Ebola Grand Challenge | 0.636473 |
| PPE-related questions | 0.478285 |
| Ebola response | 0.564145 |
| large scale | 0.476573 |
| volunteer organizations | 0.478112 |
| healthcare workers | 0.721359 |
| West Africa | 0.65684 |
| new perspective | 0.479262 |
| long-term needs | 0.48028 |
|
CLICK HERE |
| 16083 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Learning Connection homepage |
Connect to information about public health training opportunities developed by CDC, CDC partners, and other federal agencies. |
| United States | 0.444084 |
| seven-module curriculum | 0.457637 |
| health equity | 0.456384 |
| free continuing education | 0.827852 |
| health inequities | 0.484433 |
| source | 0.329268 |
| opioid overdose epidemic | 0.611242 |
| social determinants | 0.465953 |
| health disparities | 0.474134 |
| free ce | 0.783995 |
| public health courses | 0.562642 |
| Locate opioid-related courses | 0.569287 |
| federal agencies | 0.474463 |
| interactive course | 0.452341 |
|
| social media | 0.467599 |
| e-newsletter | 0.340867 |
| influenza vaccine | 0.461487 |
| CDC Learning Connection | 0.96614 |
| CDC partners | 0.55539 |
| sexually transmitted diseases | 0.607889 |
| Access thousands | 0.442448 |
| public health training | 0.615189 |
| latest practice-oriented guidelines | 0.592499 |
| website features | 0.472589 |
| STDs | 0.341583 |
| flu season | 0.456117 |
| information | 0.329233 |
| training opportunities | 0.461434 |
|
CLICK HERE |